Treating genital herpes reduces HIV transmission.

  Most people with sexually acquired HIV also have herpes simplex virus type 2 (HSV-2), the cause of genital herpes.

  Co-infection with both HIV and HSV-2 is associated with increased genital HIV shedding, which may increase HIV transmission. HIV is actually shed from genital ulcers caused by HSV-2. And several HSV-2 proteins can reactivate dormant HIV infection.

  Some evidence shows suppressing HSV-2 with valcyclovir (Valtrex) reduces HIV levels in the blood and in genital secretions. It was hoped that this would translate into reduced HIV progression or transmission.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote